Not applicableStudy completedNCT01138306What this trial is testingBiomarkers in Samples From Young Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Not applicableUnknownNCT00607984What this trial is testingAdministration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid TumorsWho this might be right forCentral Nervous System TumorsTumors Rabin Medical Center 20
Not applicableStudy completedNCT00142155What this trial is testingCorrelation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's MacroglobulinemiaWho this might be right forWaldenstrom's Macroglobulinemia Dana-Farber Cancer Institute 300
Early research (Phase 1)Looking for participantsNCT06326411What this trial is testingInvestigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsWho this might be right forOncologyMEK MutationRAF Gene Mutation+6 more Nested Therapeutics, Inc 230
Not applicableStudy completedNCT02158052What this trial is testingCombined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal DiseaseWho this might be right forMultiple MyelomaAmyloidosis Massachusetts General Hospital 2
Early research (Phase 1)Study completedNCT00499135What this trial is testingSunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid TumorsWho this might be right forAdult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT05279690What this trial is testingPilot Trial of Colchicine in Urothelial Cancer and Other Solid TumorsWho this might be right forUrothelial CancerMetastatic Solid Tumor Icahn School of Medicine at Mount Sinai 16
Testing effectiveness (Phase 2)Looking for participantsNCT07024784What this trial is testingAssess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesWho this might be right forGynecologic CancersPlatinum-Sensitive Ovarian CancerFallopian Tube Cancer+1 more AbbVie 377
Early research (Phase 1)Active Not RecruitingNCT03401385What this trial is testingFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Who this might be right forHormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer Daiichi Sankyo Co., Ltd. 890
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07780318What this trial is testingBL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid TumorsWho this might be right forGastrointestinal TumorsSolid Tumors Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00019097What this trial is testingVaccine Therapy in Treating Patients With Multiple MyelomaWho this might be right forStage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT04890613What this trial is testingStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationWho this might be right forAdvanced Solid Tumor Senhwa Biosciences, Inc. 52
Early research (Phase 1)Looking for participantsNCT06128148What this trial is testingPhase I Study of JYP0322 in ROS1 Fusion-Positive Solid TumorsWho this might be right forProtein Kinase InhibitorsOther Protocol Specified CriteriaLung Neoplasms+1 more Guangzhou JOYO Pharma Co., Ltd 101
Not applicableLooking for participantsNCT05663515What this trial is testingA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering DrugsWho this might be right forPancreatic Cancer AstraZeneca 24,000
Testing effectiveness (Phase 2)Study completedNCT02810990What this trial is testingBosutinib in Elderly Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 65
Testing effectiveness (Phase 2)Study completedNCT02280785What this trial is testingBrentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin LymphomasWho this might be right forNon-Hodgkin Lymphoma Samsung Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT02125318What this trial is testingAnagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow DisordersWho this might be right forThrombocytosisMyeloproliferative Neoplasms Galena Biopharma, Inc. 18
Not applicableNot Yet RecruitingNCT07656740What this trial is testingNon-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI CancersWho this might be right forGastrointestinal CancerColorectal (Colon or Rectal) CancerStomach (Gastric) Cancer Peking University Cancer Hospital & Institute 50
Testing effectiveness (Phase 2)Looking for participantsNCT06677190What this trial is testingBelzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginWho this might be right forOvarian CancerOvarian CarcinomaEndometrial Cancer+5 more Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT07336446What this trial is testingA Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer DrugsWho this might be right forProstate Cancer AstraZeneca 300